Epidemiologic Characteristics in Patients with Diabetes in the State of Mexico

José Raymundo Rodríguez Moctezuma; Juan Manuel López Carmona; Jesús Rodríguez Pérez; José Alfredo Jiménez Méndez

2003, Number 5

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2003; 41 (5)

Epidemiologic Characteristics in Patients with Diabetes in the State of Mexico

Rodríguez MJR, López CJM, Rodríguez PJ, Jiménez MJA

Full text

How to cite this article

Language: Spanish
References: 14
Page: 383-392
PDF size: 201.48 Kb.

ABSTRACT

Objective: To determine epidemiologic and clinical characteristics of diabetes mellitus in the Eastern State of Mexico Delegation. Material and Methods: A cross-sectional study was conducted between July 1999 and June 2000 by means of a census of diabetic patients regis-tered in the 44 units of family medicine. The socio-demographic and clinical variables were obtained in a specifically designed document. Results: A total of 44 458 diabetic subjects were registered, with a sub-registration estimated at 21 %. The adjusted diabetes prevalence was 3.9 % in subjects with age ≥ 20 years; 62.3 % were women and 98% had type 2 diabetes. The direct relatives by patient were 5.3 ± 2.9, which results in a population at risk of developing diabe-tes of 294 531 individuals. The glycemia average was 181.05 ± 71 mg/dL; only 23.9 % had glycemia ‹ 126 mg/dL. Obesity was reported in 56.2% and hypertension in 41.2 %. The treat-ments indicated were diet 72 %, exercise 42.3 %, hypoglycemic agents 70.6 %, and insulin 15.7 %. Ophthalmic disease was reported in 10.7 %, nephropathy in 9 %, coronary heart disease in 4 %, and stroke in 1.6 %. Conclusions: The magnitude and transcendence of diabetes represents a serious health problem in the Eastern State of Mexico Delegation; high social and economic costs that this generates require urgent actions to improve prevention and treatment.

REFERENCES

1. Llanos G, Libman I. La diabetes en las Américas. Bol Oficina Sanit Panam 1995;118(1):1-15.
2. Quibrera-Infante R, Hernández-Rodríguez HG, Aradillas-García C, González-Rodríguez S, Calles-Escandón J. Prevalencias de diabetes, intolerancia a la glucosa, hiperlipemia y factores de riesgo en función del nivel socioeconómico. Rev Invest Clin 1994;46:25-36.
3. González-Villalpando C, Stein PM, Villapando E, Hazuda H, Haffner SM, Lisci E. Prevalencia de diabetes e intolerancia a la glucosa en población urbana de nivel económico bajo. Rev Invest Clin 1992;44:321-328.
4. Vázquez-Robles M, Romero-Romero E, Escandón-Romero C, Escobedo-de-la-Peña J. Prevalencia de diabetes mellitus no insulino dependiente y factores de riesgo asociados, en una población de México, D.F. Gac Med Mex 1993;129:191-199.
5. Encuesta Nacional de Salud 2000. Programa de acción: diabetes mellitus. México: Secretaría de Salud; 2001. p. 11-22.
6. Phillips M, Salmerón J. Diabetes in Mexico. A se-rious and growing problem. Rapp Trimmest Statist Sanit Mond 1992;45:338-346.
7. Rico-Verdín B, Arriaga-Pérez MA, Gómez-Pérez JG, Campos-Aragón L, Escobedo-de-la-Peña J. Prevalencia de diabetes mellitus y eficiencia diagnóstica del programa de detección oportuna en una unidad de medicina familiar. Rev Med IMSS 1995;33:299-305.
8. Lee-Ramos AF, Ramírez-Ojedo J, Flores-Bustamante HI. Estudio de egresos hospitalarios de diabetes mellitus durante 7 años a nivel nacional en el Ins-tituto Mexicano del Seguro Social. 1980-1986. Rev Med IMSS 1989;27:141-146.
9. Rodríguez-Moctezuma JR, Munguía-Miranda C, López-Carmona JM, Hernández-Santiago JL, Casas de-la-Torre E. Egresos de pacientes diabéticos en un hospital general regional. Análisis de 7 años. Rev Med IMSS 2001;39(2):121-126.
Harris M. Undiagnosed NIDDM: Clinical and public health issues. Diabetes Care 1993;16:642-652.
The Expert Committee on the Diagnosis and Clas-sification of Diabetes Mellitus. Report of The Expert Committee on the Diagnosis and Classification of Dia-betes Mellitus. Diabetes Care 2001;24(Suppl 1):S5-S20.
American Diabetes Association. Diabetic nephro-pathy. Diabetes Care 2000;23 (Suppl 1):S69-S72.
UKPDS Group 33. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-852.
Velázquez-Monroy O, Peralta-Rosas M, Lara-Esqueda A, Pastelín-Hernández G. Hipertensión arterial en México: Resultados de la Encuesta Nacional de Salud (Ensa) 2000. Arch Cardiol Mex 2002;72:71-84.